The characterization of the molecular landscape of HNSCC has revealed several driver genes involved in head and neck carcinogenesis, such as TP53, CDKN2A, PIK3CA, NOTCH1, FAT1, or EGFR, representing an opportunity for developing molecular targeted therapies. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.